{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T01:27:41Z","timestamp":1769736461789,"version":"3.49.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002947","name":"Anhui Medical University","doi-asserted-by":"publisher","award":["2023xkjT024"],"award-info":[{"award-number":["2023xkjT024"]}],"id":[{"id":"10.13039\/501100002947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.cellsig.2025.111817","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T11:50:15Z","timestamp":1744804215000},"page":"111817","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["TDH-11 inhibits the proliferation and colonization of colorectal cancer by reducing the activity of HDAC"],"prefix":"10.1016","volume":"132","author":[{"given":"Rulei","family":"Zhong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenyang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shixin","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaige","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihui","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huabing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingbing","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellsig.2025.111817_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cellsig.2025.111817_bb0010","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","article-title":"Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN","volume":"72","author":"Morgan","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.cellsig.2025.111817_bb0015","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","article-title":"Cancer statistics in China and United States, 2022: Profiles, trends, and determinants","volume":"135","author":"Xia","year":"2022","journal-title":"Chinese Med. J-Peking."},{"key":"10.1016\/j.cellsig.2025.111817_bb0020","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.puhe.2024.06.008","article-title":"Burden of gastrointestinal cancers among people younger than 50 years in China, 1990 to 2019","volume":"234","author":"Liu","year":"2024","journal-title":"Public Health"},{"key":"10.1016\/j.cellsig.2025.111817_bb0025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.puhe.2023.11.038","article-title":"Burden and trend of dietary risk\u2013related colorectal cancer in China and its provinces: findings from the global burden of disease study 2019","volume":"230","author":"Liu","year":"2024","journal-title":"Public Health"},{"key":"10.1016\/j.cellsig.2025.111817_bb0030","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023, CA","volume":"73","author":"Siegel","year":"2023","journal-title":"Cancer J. Clin."},{"key":"10.1016\/j.cellsig.2025.111817_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188623","article-title":"Drug resistance in colorectal cancer: an epigenetic overview","volume":"1876","author":"Luo","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.cellsig.2025.111817_bb0040","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3322\/caac.21728","article-title":"Clinical management of metastatic colorectal cancer in the era of precision medicine, CA","volume":"72","author":"Ciardiello","year":"2022","journal-title":"Cancer J. Clin."},{"key":"10.1016\/j.cellsig.2025.111817_bb0045","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41575-022-00736-1","article-title":"Therapeutic landscape and future direction of metastatic colorectal cancer","volume":"20","author":"Bando","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cellsig.2025.111817_bb0050","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/s41575-019-0189-8","article-title":"Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies","volume":"16","author":"Keum","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cellsig.2025.111817_bb0055","first-page":"262","article-title":"The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection, the lancet","volume":"7","author":"Patel","year":"2022","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.cellsig.2025.111817_bb0060","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.3390\/ijms25063358","article-title":"Epigenetic alteration in colorectal Cancer: potential diagnostic and prognostic implications","volume":"25","author":"Cao","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellsig.2025.111817_bb0065","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.2174\/0929867328666210915105929","article-title":"Histone Deacetylases and their Inhibitors in Colorectal Cancer Therapy:Current Evidence and Future Considerations","volume":"29","author":"Garmpis","year":"2022","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.cellsig.2025.111817_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109778","article-title":"A novel HDAC1\/2 inhibitor suppresses colorectal cancer through apoptosis induction and cell cycle regulation","volume":"352","author":"Lee","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cellsig.2025.111817_bb0075","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.91316","article-title":"Nardilysin controls intestinal tumorigenesis through HDAC1\/p53\u2013dependent transcriptional regulation","volume":"3","author":"Kanda","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.cellsig.2025.111817_bb0080","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1016\/j.apsb.2023.02.007","article-title":"Targeting histone deacetylases for cancer therapy: trends and challenges","volume":"13","author":"Liang","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.cellsig.2025.111817_bb0085","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/ajh.26088","article-title":"A phase I\/ II study of the combination of panobinostat and carfilzomib in patients with relapsed or relapsed\/refractory multiple myeloma: final analysis of second dose-expansion cohort","volume":"96","author":"Berdeja","year":"2021","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.cellsig.2025.111817_bb0090","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13045-017-0439-6","article-title":"Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China","volume":"10","author":"Shi","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.cellsig.2025.111817_bb0095","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-006857","article-title":"Valproic acid increases CAR T cell cytotoxicity against acute myeloid leukemia","volume":"11","author":"Wen","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.cellsig.2025.111817_bb0100","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ebiom.2019.07.053","article-title":"Novel cell adhesion\/migration pathways are predictive markers of HDAC inhibitor resistance in cutaneous T cell lymphoma","volume":"46","author":"Andrews","year":"2019","journal-title":"eBioMedicine"},{"key":"10.1016\/j.cellsig.2025.111817_bb0105","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13045-017-0495-y","article-title":"Preclinical anti-myeloma activity of EDO-S101, a new bendamustine-derived molecule with added HDACi activity, through potent DNA damage induction and impairment of DNA repair","volume":"10","author":"L\u00f3pez-Iglesias","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.cellsig.2025.111817_bb0110","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/s41419-023-06205-0","article-title":"Targeting the E2F1\/Rb\/HDAC1 axis with the small molecule HR488B effectively inhibits colorectal cancer growth","volume":"14","author":"Duan","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellsig.2025.111817_bb0115","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.4161\/auto.29231","article-title":"Combined autophagy and HDAC inhibition: a phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor vorinostat in patients with advanced solid tumors","volume":"10","author":"Mahalingam","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.cellsig.2025.111817_bb0120","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1158\/0008-5472.CAN-10-2430","article-title":"The dual EGFR\/HER2 inhibitor Lapatinib synergistically enhances the antitumor activity of the histone deacetylase inhibitor Panobinostat in colorectal Cancer models","volume":"71","author":"LaBonte","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2025.111817_bb0125","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/oncolo\/oyac078","article-title":"Phase I trial of Regorafenib, hydroxychloroquine, and Entinostat in metastatic colorectal Cancer","volume":"27","author":"Karasic","year":"2022","journal-title":"Oncologist"},{"key":"10.1016\/j.cellsig.2025.111817_bb0130","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/s41591-024-02813-1","article-title":"Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS\/pMMR colorectal cancer: a randomized phase 2 trial","volume":"30","author":"Wang","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellsig.2025.111817_bb0135","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1007\/s00277-024-05691-2","article-title":"A real-world pharmacovigilance study investigating the toxicities of histone deacetylase inhibitors","volume":"103","author":"Li","year":"2024","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.cellsig.2025.111817_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105992","article-title":"SAR study culminates in a series of HDAC6 selective inhibitors featuring Schisandrin C-analogous cap as potential immunomodulatory agents for cancer therapy","volume":"127","author":"Tao","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.cellsig.2025.111817_bb0145","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/s41575-024-00934-z","article-title":"Mechanisms of metastatic colorectal cancer","volume":"21","author":"Ca\u00f1ellas-Socias","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cellsig.2025.111817_bb0150","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s10555-023-10158-3","article-title":"Colorectal cancer: a comprehensive review of carcinogenesis, diagnosis, and novel strategies for classified treatments","volume":"43","author":"Abedizadeh","year":"2023","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.cellsig.2025.111817_bb0155","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1186\/s12885-020-06904-3","article-title":"Evaluation of adverse effects of chemotherapy regimens of 5-fluoropyrimidines derivatives and their association with DPYD polymorphisms in colorectal cancer patients","volume":"20","author":"Negarandeh","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cellsig.2025.111817_bb0160","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/s41419-022-04571-9","article-title":"Suppression of histone deacetylase 1 by JSL-1 attenuates the progression and metastasis of cholangiocarcinoma via the TPX2\/snail axis","volume":"13","author":"Xu","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellsig.2025.111817_bb0165","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s10565-021-09673-2","article-title":"Targeting histone deacetylase-3 blocked epithelial-mesenchymal plasticity and metastatic dissemination in gastric cancer","volume":"39","author":"Wu","year":"2022","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.cellsig.2025.111817_bb0170","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1002\/cam4.4059","article-title":"Trichostatin a promotes esophageal squamous cell carcinoma cell migration and EMT through BRD4\/ERK1\/2-dependent pathway","volume":"10","author":"Liu","year":"2021","journal-title":"Cancer Med."},{"key":"10.1016\/j.cellsig.2025.111817_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2021.110202","article-title":"KIAA1522 is a new biomarker of promoting the tumorigenesis and distant metastasis of colorectal carcinoma","volume":"90","author":"Yi","year":"2022","journal-title":"Cell. Signal."},{"key":"10.1016\/j.cellsig.2025.111817_bb0180","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1158\/1541-7786.MCR-22-0552","article-title":"USP10 regulates ZEB1 ubiquitination and protein stability to inhibit ZEB1-mediated colorectal cancer metastasis","volume":"21","author":"Sun","year":"2023","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.cellsig.2025.111817_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154303","article-title":"Berberine inhibited the formation of metastasis by intervening the secondary homing of colorectal cancer cells in the blood circulation to the lung and liver through HEY2","volume":"104","author":"Ni","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.cellsig.2025.111817_bb0190","doi-asserted-by":"crossref","first-page":"6937","DOI":"10.1002\/jcb.27743","article-title":"Long noncoding RNA GAS5 inhibits angiogenesis and metastasis of colorectal cancer through the Wnt\/\u03b2-catenin signaling pathway","volume":"120","author":"Song","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.cellsig.2025.111817_bb0195","doi-asserted-by":"crossref","first-page":"1007579","DOI":"10.3389\/fimmu.2022.1007579","article-title":"The development and improvement of immunodeficient mice and humanized immune system mouse models","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellsig.2025.111817_bb0200","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.cellimm.2018.03.010","article-title":"The role of hepatic macrophages in liver metastasis","volume":"330","author":"Keirsse","year":"2018","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.cellsig.2025.111817_bb0205","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00946","article-title":"Hepatic natural killer cells: organ-specific sentinels of liver immune homeostasis and physiopathology","volume":"10","author":"Mikulak","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellsig.2025.111817_bb0210","doi-asserted-by":"crossref","DOI":"10.1002\/cbf.3969","article-title":"Cells in the liver microenvironment regulate the process of liver metastasis","volume":"42","author":"Wang","year":"2024","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.cellsig.2025.111817_bb0215","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41568-023-00568-4","article-title":"Dissecting metastasis using preclinical models and methods","volume":"23","author":"Hebert","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cellsig.2025.111817_bb0220","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.trsl.2022.07.003","article-title":"Recent advances in the development of transplanted colorectal cancer mouse models","volume":"249","author":"Yang","year":"2022","journal-title":"Transl. Res."},{"key":"10.1016\/j.cellsig.2025.111817_bb0225","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.3390\/cancers13122991","article-title":"PDLIM2 suppression inhibit proliferation and metastasis in kidney Cancer","volume":"13","author":"Yuk","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cellsig.2025.111817_bb0230","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.3390\/ijms20102415","article-title":"p53 at the crossroads between different types of HDAC inhibitor-mediated Cancer cell death","volume":"20","author":"Mrakovcic","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellsig.2025.111817_bb0235","doi-asserted-by":"crossref","first-page":"6649","DOI":"10.3390\/molecules28186649","article-title":"Anti-colorectal Cancer activity of Solasonin from Solanum nigrum L. via histone deacetylases-mediated p53 acetylation pathway","volume":"28","author":"Lan","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.cellsig.2025.111817_bb0240","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.3390\/ijms19092743","article-title":"A new synthetic histone deacetylase inhibitor, MHY2256, induces apoptosis and autophagy cell death in endometrial Cancer cells via p53 acetylation","volume":"19","author":"De","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellsig.2025.111817_bb0245","doi-asserted-by":"crossref","first-page":"11171","DOI":"10.1074\/jbc.M809268200","article-title":"p53 acetylation is crucial for its transcription-independent Proapoptotic functions","volume":"284","author":"Yamaguchi","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2025.111817_bb0250","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1158\/0008-5472.CAN-07-5807","article-title":"Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1\/2","volume":"68","author":"Lin","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2025.111817_bb0255","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood-2012-08-450916","article-title":"Dosage-dependent tumor suppression by histone deacetylases 1 and 2 through regulation of c-Myc collaborating genes and p53 function","volume":"121","author":"Heideman","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.cellsig.2025.111817_bb0260","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.154","article-title":"Natural HDAC-1\/8 inhibitor baicalein exerts therapeutic effect in CBF-AML","volume":"10","author":"Yu","year":"2020","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.cellsig.2025.111817_bb0265","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13045-024-01551-8","article-title":"Advances in targeting histone deacetylase for treatment of solid tumors","volume":"17","author":"Shi","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.cellsig.2025.111817_bb0270","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00432-019-03118-4","article-title":"Histone deacetylase inhibitors dysregulate DNA repair proteins and antagonize metastasis-associated processes","volume":"146","author":"Kiweler","year":"2020","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.cellsig.2025.111817_bb0275","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s40264-018-0773-9","article-title":"Safety and tolerability of histone deacetylase (HDAC) inhibitors in oncology","volume":"42","author":"Shah","year":"2019","journal-title":"Drug Saf."},{"key":"10.1016\/j.cellsig.2025.111817_bb0280","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.1158\/1078-0432.CCR-23-1795","article-title":"Entinostat enhances the efficacy of chemotherapy in small cell lung Cancer through S-phase arrest and Decreased Base excision repair","volume":"29","author":"Solta","year":"2023","journal-title":"Clin. Cancer Res."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089865682500230X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089865682500230X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T12:24:08Z","timestamp":1769689448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089865682500230X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":56,"alternative-id":["S089865682500230X"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.111817","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TDH-11 inhibits the proliferation and colonization of colorectal cancer by reducing the activity of HDAC","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.111817","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111817"}}